Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation

By sjmartinez • October 15, 2023

Armstrong AW, Elston CA, Elewski BE, Ferris LK, Gottlieb AB, Lebwohl MG; Medical Board of the National Psoriasis Foundation.. Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation. J Am Acad Dermatol. 2023 Oct 12:S0190-9622(23)02969-9. doi: 10.1016/j.jaad.2023.09.080. Epub ahead of print. PMID: 37838256.

Tags: access, consensus statement, Dermatology, generalized pustular psoriasis, IL-36 inhibition, imsidolimab, national psoriasis foundation, psoriasis, Publications, spesolimab, therapy, Treatment

Contact Dermatitis in the United States: A Population-Based Study on Patient Visit Characteristics and Treatment Prescription Patterns

Hao A, Yu RP, Kikuchi R, Sadrolashrafi K, Guo L, Yamamoto RK, Tolson H, Yee D, Bilimoria S, Pourali SP, Adler BL, Armstrong AW. Contact[...]

Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report

Biba U, Poppens MJ, Collier EK, Cheng K. Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report.[...]

Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.